Fosamprenavir

In the US, Fosamprenavir (fosamprenavir systemic) is a member of the drug class protease inhibitors and is used to treat HIV Infection and Nonoccupational Exposure.

US matches:

• Fosamprenavir


• Fosamprenavir Suspension


• Fosamprenavir Calcium

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J05AE07

CAS registry number (Chemical Abstracts Service)

0226700-79-4

Chemical Formula

C25-H36-N3-O9-P-S

Molecular Weight

585

Therapeutic Category

Antiviral agent, HIV protease inhibitor

Chemical Names

(3S)-tetrahydro-3-furyl [(α S)-α-[(1R)-1-hydroxy-2-(N¹-isobutylsulfanil=amido)ethyl]phenethyl]carbamate, dihydrogen phosphate (ester) (WHO)

(S)-Tetrahydro-3-furyl{(αS)-α-[(R)-1-(dihydroxyphosphoryloxy)-2-(N-isobutylsulfanilamido) ethyl]phenethyl}carbamat (IUPAC)

Foreign Names

• Fosamprenavirum (Latin)
• Fosamprenavir (German)
• Fosamprénavir (French)
• Fosamprenavir (Spanish)

Generic Names

• fAPV (IS)
• GW 433908 (IS: GlaxoSmithKline)
• VX 175 (IS: Vertex)
• Fosamprenavir Calcium (OS: USAN)
• 908 (IS)
• GW 433908G (IS)
• VX-175 (IS)

Brand Names

• Telzer
  GlaxoSmithKline, Mexico



• Telzir
  GlaxoSmithKline, Colombia; GlaxoSmithKline, Ireland; GlaxoSmithKline, Romania; GlaxoSmithKline, Turkey



• Levixa
  GlaxoSmithKline, Japan



• Lexiva
  GlaxoSmithKline, Israel; ViiV Healthcare, United States



• Telzir
  Glaxo Group, Austria; Glaxo Group Limited-GB, Italy; Glaxo SmithKline, Spain; Glaxo Wellcome, Portugal; GlaxoGroup, Netherlands; GlaxoSmithKline, Antigua & Barbuda; GlaxoSmithKline, Netherlands Antilles; GlaxoSmithKline, Argentina; GlaxoSmithKline, Australia; GlaxoSmithKline, Aruba; GlaxoSmithKline, Barbados; GlaxoSmithKline, Belgium; GlaxoSmithKline, Bermuda; GlaxoSmithKline, Bahamas; GlaxoSmithKline, Canada; GlaxoSmithKline, Chile; GlaxoSmithKline, Costa Rica; GlaxoSmithKline, Czech Republic; GlaxoSmithKline, Germany; GlaxoSmithKline, Denmark; GlaxoSmithKline, Dominican Republic; GlaxoSmithKline, Finland; GlaxoSmithKline, France; GlaxoSmithKline, United Kingdom; GlaxoSmithKline, Grenada; GlaxoSmithKline, Guatemala; GlaxoSmithKline, Guyana; GlaxoSmithKline, Honduras; GlaxoSmithKline, Honduras; GlaxoSmithKline, Hungary; GlaxoSmithKline, Ireland; GlaxoSmithKline, Iceland; GlaxoSmithKline, Jamaica; GlaxoSmithKline, Cayman Islands; GlaxoSmithKline, Saint Lucia; GlaxoSmithKline, Luxembourg; GlaxoSmithKline, Nicaragua; GlaxoSmithKline, Norway; GlaxoSmithKline, Panama; GlaxoSmithKline, Serbia; GlaxoSmithKline, Sweden; GlaxoSmithKline, El Salvador; GlaxoSmithKline, Trinidad & Tobago; GlaxoSmithKline, South Africa; ViiV, Switzerland

International Drug Name Search

Glossary

IUPAC	International Union of Pure and Applied Chemistry
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.